Balance Sheet - Janux Therapeutics, Inc. (JANX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 966.57 | 1,025.17 | 344.03 | 327.02 | 374.97 | 7.81 | 0.66 |
| Accounts receivable, net | 6.43 | 5.38 | 2.20 | 0.70 | 0.20 | 8.00 | 0.00 |
| Inventories | -2.20 | -0.70 | -0.20 | ||||
| Other current assets | 2.89 | 3.11 | 5.21 | 5.42 | 2.05 | 0.25 | |
| Total current assets | 975.89 | 1,033.67 | 349.24 | 332.44 | 377.02 | 16.06 | 0.66 |
| Total non-current assets | 31.64 | 27.85 | 31.17 | 31.57 | 2.81 | 0.16 | 0.02 |
| Total assets | 1,007.52 | 1,061.52 | 380.41 | 364.01 | 379.82 | 16.22 | 0.68 |
| Total current liabilities | 25.00 | 17.46 | 13.03 | 16.51 | 12.80 | 3.18 | 4.63 |
| Total non-current liabilities | 25.70 | 21.28 | 23.03 | 26.76 | 0.70 | 27.67 | 4.00 |
| Total liabilities | 50.70 | 38.74 | 36.06 | 43.27 | 13.50 | 30.86 | 8.62 |
| Total stockholders' equity | 956.82 | 1,022.78 | 344.35 | 320.74 | 366.33 | -14.64 | -7.94 |
| Common shares outstanding | 62 | 54 | 44 | 41 | 41 | 42 | 42 |
Show Quarterly Balance Sheet
Balance Sheet - Janux Therapeutics, Inc. (JANX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 956.39 | 966.57 | 988.99 | 996.01 | 1,014.15 | 1,025.17 | 658.03 | 646.29 | 651.76 | 344.03 | 349.71 | 303.29 | 316.88 | 327.02 | 338.76 | 354.30 | 361.20 | 374.97 | 387.51 | 394.20 | 70.77 | 7.81 | 0.00 | 0.00 | 0.66 |
| Accounts receivable, net | 42.46 | 6.43 | 6.32 | 5.69 | 5.59 | 5.38 | 4.45 | 12.06 | 4.41 | 2.20 | 1.70 | 1.50 | 0.75 | 0.70 | 0.50 | 0.30 | 0.10 | 0.20 | 0.03 | 0.38 | 0.38 | 8.00 | |||
| Inventories | 0.00 | -2.20 | -1.70 | -1.50 | -0.70 | 0.00 | -0.30 | -0.10 | -0.20 | -0.03 | |||||||||||||||
| Other current assets | 3.20 | 2.89 | 2.78 | 3.85 | 3.61 | 3.11 | 3.84 | 3.59 | 2.50 | 5.21 | 5.48 | 6.01 | 3.77 | 5.42 | 5.07 | 3.77 | 3.45 | 2.05 | 2.08 | 2.04 | 0.26 | 0.25 | |||
| Total current assets | 1,002.05 | 975.89 | 998.09 | 1,005.55 | 1,023.34 | 1,033.67 | 666.32 | 661.94 | 658.67 | 349.24 | 355.20 | 309.30 | 321.40 | 332.44 | 344.33 | 358.07 | 364.65 | 377.02 | 389.59 | 396.61 | 71.41 | 16.06 | 0.66 | ||
| Total non-current assets | 26.18 | 31.64 | 26.68 | 26.66 | 27.43 | 27.85 | 28.70 | 29.47 | 30.32 | 31.17 | 31.66 | 32.20 | 31.56 | 31.57 | 31.43 | 27.30 | 3.94 | 2.81 | 1.50 | 0.22 | 0.41 | 0.16 | -0.66 | ||
| Total assets | 1,028.23 | 1,007.52 | 1,024.77 | 1,032.21 | 1,050.77 | 1,061.52 | 695.02 | 691.41 | 688.98 | 380.41 | 386.85 | 341.50 | 352.96 | 364.01 | 375.76 | 385.37 | 368.60 | 379.82 | 391.08 | 396.82 | 71.82 | 16.22 | |||
| Total current liabilities | 58.92 | 25.00 | 27.83 | 21.38 | 17.50 | 17.46 | 17.17 | 11.55 | 10.61 | 13.03 | 14.47 | 17.90 | 16.11 | 16.51 | 16.34 | 12.99 | 12.52 | 12.80 | 12.47 | 9.21 | 6.89 | 3.18 | |||
| Total non-current liabilities | 27.78 | 25.70 | 20.38 | 20.32 | 20.80 | 21.28 | 21.74 | 22.19 | 22.61 | 23.03 | 23.43 | 24.13 | 25.58 | 26.76 | 27.91 | 28.56 | 6.74 | 0.70 | 1.86 | 2.82 | 81.70 | 27.67 | |||
| Total liabilities | 86.69 | 50.70 | 48.21 | 41.70 | 38.30 | 38.74 | 38.92 | 33.74 | 33.22 | 36.06 | 37.90 | 42.03 | 41.69 | 43.27 | 44.24 | 41.55 | 12.52 | 13.50 | 14.33 | 12.03 | 88.59 | 30.86 | |||
| Total stockholders' equity | 941.54 | 956.82 | 976.56 | 990.52 | 1,012.47 | 1,022.78 | 656.10 | 657.68 | 655.76 | 344.35 | 348.95 | 299.47 | 311.26 | 320.74 | 331.51 | 343.81 | 356.08 | 366.33 | 376.75 | 384.80 | -16.77 | -14.64 | -3.95 | ||
| Common shares outstanding | 63 | 62 | 62 | 62 | 62 | 57 | 55 | 54 | 49 | 47 | 46 | 42 | 42 | 42 | 42 | 41 | 41 | 41 | 41 | 10 | 40 | 12 | 12 | 12 | 12 |